Mechanism of reductive activation of a 5-nitroimidazole by flavoproteins: model studies with dithionite.
The flavoprotein nitroreductases NADPH:cytochrome P-450 reductase and xanthine oxidase catalyzed the cofactor-dependent anaerobic nitro group reduction and covalent binding to protein sulfhydryl groups of the 5-nitroimidazole substrate ronidazole [1-methyl-5-nitroimidazole-2-yl)-methyl carbamate). Studies with variously radiolabeled ronidazole molecules demonstrated that the imidazole ring was intact while greater than 80% of the C-4 3H and 2-carbamoyl group were lost from the covalently bound product. The stoichiometry of cofactor consumption during the enzyme-catalyzed reduction of the substrate could not be determined, so a model nitroreductase system which utilized dithionite as the reductant and agarose-immobilized cysteine as the target for alkylation was developed. Two moles of dithionite was consumed per mole of substrate for maximal reduction of uv absorbance due to the nitro group, for maximal release of C-4 3H, and for maximal covalent binding to agarose-immobilized cysteine. These results indicate that four electrons are required for the reductive activation of the substrate, consistent with formation of a hydroxylamine reactive intermediate. Covalent binding of variously radiolabeled substrate molecules after dithionite reduction exhibited the same labeling pattern as flavoprotein-catalyzed covalent binding, suggesting that covalent binding is mediated by the same species in both chemical and biological systems. The data are consistent with a mechanism where the substrate undergoes four-electron reduction to form a hydroxylamine, which is susceptible to nucleophilic attack at C-4. When water attacks C-4, the 2-carbamoyl group can eliminate to form a Michael-like acceptor which adds thiols at the 2-methylene position.
D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004227:Dithionite / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism*; D009593:Nitroimidazoles / Q000378:metabolism*; D009601:Nitroreductases / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012385:Ronidazole / Q000378:metabolism; D013447:Sulfites / Q000494:pharmacology*; D014969:Xanthine Oxidase / Q000378:metabolism*
D009593:Nitroimidazoles; D013447:Sulfites; D004227:Dithionite; D012385:Ronidazole; D014969:Xanthine Oxidase; D009251:NADPH-Ferrihemoprotein Reductase; D009601:Nitroreductases; C052587:4-nitroimidazole